Network analysis of optimal deep or machine learning strategies for classification and detection of Alzheimer's...

Alzheimer's disease (AD) presents a significant global health challenge, with its prevalence projected to increase substantially by 2050. Despite its widespread impact, the underlying causes and mechanisms remain incompletely understood, complicating efforts toward effective diagnosis and treatment. Pathologically, AD is marked by the accumulation of senile plaques and neurofibrillary tangles, but the relationship between these factors and disease progression is complex and heterogeneous.

The present study aimed to compare the efficacy of different deep/machine learning models based on MRI scanning.

The study follows rigorous systematic review protocols, adhering to the Cochrane Handbook of Systematic Reviews and Interventions and the PRISMA guidelines. A comprehensive search strategy was employed across multiple databases, including PubMed, Web of Science, Cochrane, Medline, and EMBASE. Advanced statistical methods were used for data synthesis and analysis, incorporating network meta-analysis and machine learning techniques to evaluate the accuracy and efficacy of different diagnostic models.

The meta-analysis included 11 studies that met the predefined inclusion criteria. The studies employed various machine learning algorithms, including CNN, ResNet, and DenseNet, to classify AD and distinguish it from mild cognitive impairment (MCI) and healthy controls. The results indicate that CNN and ResNet consistently outperform other models in terms of classification accuracy. Additionally, the integration of nanotechnology and AI-driven diagnostics demonstrates significant potential in enhancing the diagnostic process.

Despite challenges such as data heterogeneity and the interpretability of AI-driven models, the study highlights the transformative potential of computational techniques and advanced imaging technologies in AD diagnosis and management. The integration of network-based analyses and machine learning approaches offers promising avenues for future research, aiming to revolutionize the understanding and approach to Alzheimer's disease.